Topic: Integrating Clinical Pharmacogenetics Into Primary Care: Initial Experiences from the University of Florida

Speakers:

Meghan Arwood, PharmD, BCPS, Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy

Eric Dietrich, PharmD, BCPS, CPC-A, Clinical Assistant Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy

The UF Health Personalized Medicine Program (PMP) is a multidisciplinary, pharmacist-led initiative that provides evidence-based recommendations to providers based on pharmacogenetics (PGx) test results to guide drug/dose selection. Established in 2011, the PMP has launched 6 gene-drug pair implementations across multiple practice areas in inpatient and outpatient settings. Continued growth of the PMP, along with the collaboration of physicians, pharmacists, and informaticians, has paved the way for development of a comprehensive outpatient referral-based PGx consult clinic. In fall 2017, the PMP launched the Pharmacogenetics Consult clinic at UF Health Internal Medicine-Tower Hill (IMTH), in which IMTH providers refer patients for a face-to-face consult with a PGx expert pharmacist. The pharmacist’s role is to confirm the need for PGx testing, order the appropriate PGx test(s), provide PGx-based drug therapy recommendations to the provider, and educate patients and providers on the PGx results’ implications. Through the integration of PGx into routine outpatient practice, this innovative clinic aims to improve quality of care by reducing the trial-and-error approach to prescribing, and ultimately to improve drug-related outcomes. In this webinar, we will present on the development and implementation of this pharmacogenetics consult clinic, sharing early implementation successes and challenges.

Webinar Slides: CIWG_Arwood and Dietrich_050318_final

Webinar Recording: